Table 1.
Clinical Performance of the Mp1p Enzyme Immunoassay in 889 Study Participants, Including 372 Participants With Culture-proven Talaromycosis and 517 Non-talaromycosis Control Participants
| ODcutoff = 0.5 | Talaromycosis Cases | Non-talaromycosis Controls | Sum |
|---|---|---|---|
| TmAg positive OD ≥0.5 |
TP 321 |
FP 10 |
331 |
| TmAg negative OD <0.5 |
FN 51 |
TN 507 |
558 |
| Sum | 372 | 517 | 889 |
| Diagnostic Features | Diagnostic Values, No. (%) |
(95% CI) | |
| Sensitivity | 321/372 (86.3%) | (82.3%–89.5%) | |
| Specificity | 507/517 (98.1%) | (96.3%–99.0%) | |
| Positive likelihood ratio | |||
| Negative likelihood ratio |
Abbreviations: FN, false negative; FP, false positive; OD, optical density; TmAg, Talaromyces marneffei antigen; TN, true negative; TP, true positive.